Literature DB >> 11678932

Clinical significance of nested polymerase chain reaction and immunofluorescence for detection of Pneumocystis carinii pneumonia.

M Olsson1, K Strålin, H Holmberg.   

Abstract

OBJECTIVE: To study the clinical significance of a nested polymerase chain reaction (PCR) method compared to immunofluorescence (IF) for detection of Pneumocystis carinii.
METHODS: The medical records of 89 patients with 91 episodes of pneumonia were scrutinised retrospectively. The pneumonia episodes were divided into categories according to the likelihood that the patient had had clinical Pneumocystis carinii pneumonia (PCP). All respiratory tract samples from the 89 patients (34 broncho-alveolar lavage (BAL) and 57 sputa) were tested for Pneumocystis carinii by IF and nested PCR.
RESULTS: Fifteen episodes, as diagnosed by IF, were classified as true PCP (combination of the groups with definite and probable PCP; sensitivity 60%, specificity 97%). Among the P. carinii DNA-positive episodes, detected with nested PCR, 24 were classified as true PCP (combination of the groups with definite and probable PCP; sensitivity 96%, specificity 59%), since all IF-positive samples were nested PCR positive. Only one pneumonia episode classified as a probable PCP, was negative with both methods, as applied to a BAL sample.
CONCLUSIONS: IF applied to BAL or sputum seems to be the most specific method for diagnosis of clinical PCP. Additional clinical cases can be found by nested PCR, although this then gives a high risk of detecting subclinical colonisation of P. carinii.

Entities:  

Mesh:

Year:  2001        PMID: 11678932     DOI: 10.1046/j.1469-0691.2001.00309.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.

Authors:  Philippe M Hauser; Jacques Bille; Cornelia Lass-Flörl; Christian Geltner; Marta Feldmesser; Michael Levi; Hitesh Patel; Victoria Muggia; Barbara Alexander; Martin Hughes; Sarah A Follett; Xiaohui Cui; Flora Leung; Gillian Morgan; Adrian Moody; David S Perlin; David W Denning
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

2.  Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study.

Authors:  Catherine M Samuel; Andrew Whitelaw; Craig Corcoran; Brenda Morrow; Nei-Yuan Hsiao; Marco Zampoli; Heather J Zar
Journal:  BMC Infect Dis       Date:  2011-11-28       Impact factor: 3.090

3.  Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity.

Authors:  John W Wilson; Andew H Limper; Thomas E Grys; Theresa Karre; Nancy L Wengenack; Matthew J Binnicker
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02       Impact factor: 2.803

Review 4.  PCR-based diagnosis of human fungal infections.

Authors:  Prasanna D Khot; David N Fredricks
Journal:  Expert Rev Anti Infect Ther       Date:  2009-12       Impact factor: 5.091

5.  Pneumocystis pneumonia in South African children diagnosed by molecular methods.

Authors:  Brenda M Morrow; Catherine M Samuel; Marco Zampoli; Andrew Whitelaw; Heather J Zar
Journal:  BMC Res Notes       Date:  2014-01-10

6.  The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.

Authors:  K M Williams; K W Ahn; M Chen; M D Aljurf; A L Agwu; A R Chen; T J Walsh; P Szabolcs; M J Boeckh; J J Auletta; C A Lindemans; J Zanis-Neto; M Malvezzi; J Lister; J S de Toledo Codina; K Sackey; J L H Chakrabarty; P Ljungman; J R Wingard; M D Seftel; S Seo; G A Hale; B Wirk; M S Smith; B N Savani; H M Lazarus; D I Marks; C Ustun; H Abdel-Azim; C C Dvorak; J Szer; J Storek; A Yong; M R Riches
Journal:  Bone Marrow Transplant       Date:  2016-01-04       Impact factor: 5.483

7.  Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia.

Authors:  P Fillatre; S Chevrier; M Revest; A Gacouin; S Jouneau; H Leroy; F Robert-Gangneux; S Minjolle; Y Le Tulzo; P Tattevin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-22       Impact factor: 3.267

8.  Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia--a case-control study.

Authors:  Jannik Helweg-Larsen; Jørgen Skov Jensen; Birthe Dohn; Thomas L Benfield; Bettina Lundgren
Journal:  BMC Infect Dis       Date:  2002-11-25       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.